Ignite Creation Date:
2025-12-24 @ 11:04 PM
Ignite Modification Date:
2026-02-22 @ 6:46 PM
Study NCT ID:
NCT00539669
Status:
COMPLETED
Last Update Posted:
2007-10-04
First Post:
2007-10-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
TAX + Carboplatin or Cisplatin 1st Line Post-Surgery Ovarian
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
XRP6976I_2502
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None